Molekulare multimodale Hybridbildgebung des Prostata- und Blasenkarzinoms-Reference-Cited by-同舟云学术

Molekulare multimodale Hybridbildgebung des Prostata- und Blasenkarzinoms

Published:2014-04 Issue:4 Volume:53 Page:469-483
ISSN:0340-2592
Container-title:Der Urologe
language:de
Short-container-title:Urologe

Author:

Maurer T.,Eiber M.,Krause B.J.

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://link.springer.com/content/pdf/10.1007/s00120-014-3440-5.pdf

Reference93 articles.

1. Afshar-Oromieh A, Haberkorn U, Eder M et al (2012) [68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECH. Eur J Nucl Med Mol Imaging 39:1085–1086

2. Akduman EI, Momtahen AJ, Balci NC et al (2008) Comparison between malignant and benign abdominal lymph nodes on diffusion-weighted imaging. Acad Radiol 15:641–646

3. AWMF (2011) Interdisziplinäre Leitlinie der Qualität S3 zur Früherkennung, Diagnose und Therapie der verschiedenen Stadien des Prostatakarzinoms. AWMF, Düsseldorf

4. Barentsz JO, Richenberg J, Clements R et al (2012) ESUR prostate MR guidelines 2012. Eur Radiol 22:746–757

5. Beer AJ, Eiber M, Souvatzoglou M et al (2011) Restricted water diffusibility as measured by diffusion-weighted MR imaging and choline uptake in (11)C-choline PET/CT are correlated in pelvic lymph nodes in patients with prostate cancer. Mol Imaging Biol 13:352–361

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Muscle Invasive Bladder Cancer and the Staging Conundrum: Which Imaging Modality Is Best?;Management of Urology;2021

2. Prostate: High-Dose Rate Brachytherapy in the Treatment of Clinically Organ-Confined Prostate Cancer;Brachytherapy;2016

3. Wie wird Prostatakrebs heute diagnostiziert?;MMW - Fortschritte der Medizin;2014-12